Abstract 5887
Background
Metastatic uveal melanoma (mUM) is a rare disease with poor prognosis, hardly responding to systemic treatment. As the liver is the most common and prognostic relevant metastatic site, liver-directed therapies have come into focus.
Methods
A retrospective analysis was carried out in patients who were treated at our center between 2008 and 2017 receiving chemotherapy (1000 mg/m2 gemcitabine + 3500 mg/m2 treosulfan (GeT) on days 1 + 8, 4-week cycles) or transarterial chemoembolization (TACE, EmboCept® S microspheres + 50 mg cisplatin, every 4-6 weeks) as 1st-line therapy for mUM.
Results
287 patients were treated for mUM in the time period, 93 received TACE and 82 GeT as 1st-line therapy. Patient characteristics differed in the metastatic pattern: patients receiving GeT having a significant higher rate of non-liver dominant metastatic disease compared to the TACE group (p < 0.001), whereas there was no difference in age, sex, DFI, laboratory values and percentage of liver involvement. Median overall survival (OS) in the GeT group was 11.3 vs. 8.4 months in the TACE group (p = 0.089), with a median progression-free survival (PFS) of 2.7 and 2.8 months respectively (ns). Overall response rate for GeT was 6.8% and disease control rate was 41.1%, for TACE 10.2% and 47.7% respectively (both ns). Age, sex, baseline laboratory values, PFS and percentage of liver involvement were significantly associated with OS in univariate analysis. Multivariate Cox regression analysis identified male sex, elevated bilirubin, GGT, ALP, percentage of liver involvement >50% and PFS ≤2.7 months as significant independent prognostic factors for shorter survival. The metastatic pattern and the type of treatment did not show to be significant prognostic factors.
Conclusions
Liver-directed therapies can improve response rates compared to systemic therapies and should be preferred in patients with liver-dominant metastatic pattern. However, PFS and OS remain poor and not significantly different between intrahepatic and systemic therapies. Further research should focus on developing new therapies based on a better understanding of the biology of these tumors.
Clinical trial identification
Legal entity responsible for the study
Charité Comprehensive Cancer Center, Charité - University Medicine Berlin.
Funding
Has not received any funding.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1159 - Molecular characterization and search for founding effects in Canarian families with Hereditary Breast and Ovarian Cancer Syndrome
Presenter: Elisenda Llabres Valenti
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3725 - Effect of the polymorphism rs2066844 of the NOD2 gene on colon cancer incidence in a high cardiovascular risk population. Modulation by gender
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3708 - Effect of the polymorphisms rs1476413, rs1801131, rs4846052 and rs6541003 of the MTHFR gene on prostate cancer in a high cardiovascular risk population
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5057 - Association of a genetic variant in cyclin-dependent kinase Inhibitor 2A gene with the increased risk of breast cancer
Presenter: Soodabeh Shahid Sales
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5970 - Investigating the role of HAT protein TIP60 in regulating functional dynamics of nuclear receptor PXR
Presenter: KARISHMA BAKSHI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1360 - The role of downregulated SIRT3 expression in patients with hepatocellular carcinoma
Presenter: Hanhee Jo
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1634 - Prediction and Intervention of Colorectal Cancer Risk with Artificial Intelligent System
Presenter: Yang Ge
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4921 - Measuring the Efficiency of Cancer Care in Europe
Presenter: Rikard Althin
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1235 - Circulating cell-free DNA isolated from plasma of mesenteric veins predicts prognosis in stage II colorectal cancer patients
Presenter: Chih-Yung Yang
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5169 - _lonality of uterine carcinosarcoma as a factor of clinical prognosis.
Presenter: Natalia Levitskaya
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract